Gene ontology annotations for HIST1H2AE |
|
Experiment description of studies that identified HIST1H2AE in exosomes |
1 |
Experiment ID |
76 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20224111
|
Organism |
Homo sapiens |
Experiment description |
Proteomics analysis of bladder cancer exosomes. |
Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
Journal name |
MCP
|
Publication year |
2010 |
Sample |
Bladder cancer cells |
Sample name |
HT1376 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.10-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
2 |
Experiment ID |
21 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
19837982
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
Journal name |
MCP
|
Publication year |
2009 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1215 |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.10-1.12 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [Orbitrap] Western blotting |
|
|
3 |
Experiment ID |
207 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
4 |
Experiment ID |
208 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
5 |
Experiment ID |
209 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
6 |
Experiment ID |
226 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
GAPDH|CD9|FLOT1
|
Enriched markers |
✔
LMNA|H2AFX|ATP5A1|TOMM20
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
Small RNA sequencing (Illumina HiSeq 2000 (Solexa)
|
PubMed ID |
26027894
|
Organism |
Homo sapiens |
Experiment description |
"Quantitative and qualitative analysis of small RNAs in human endothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting" |
Authors |
"Bas W. M. van Balkom, Almut S. Eisele, D. Michiel Pegtel, Sander Bervoets, Marianne C. Verhaar" |
Journal name |
Journal of Extracellular Vesicles
|
Publication year |
2015 |
Sample |
Endothelial cells |
Sample name |
HMEC-1 |
Isolation/purification methods |
Differential ultracentrifugation Sucrose density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
miRNA Protein snoRNA lncRNA yRNA snRNA mRNA ncRNA mtRNA vtRNA scaRNA lincRNA |
Methods used in the study |
Small RNA sequencing (Illumina HiSeq 2000 (Solexa) Western blotting |
|
|
7 |
Experiment ID |
234 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-C3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
8 |
Experiment ID |
235 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
9 |
Experiment ID |
236 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
MHCC97L |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
10 |
Experiment ID |
237 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
mRNA
|
Identification method |
RNA Sequencing
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocytes |
Sample name |
MIHA |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RNA Sequencing |
|
|
11 |
Experiment ID |
126 |
MISEV standards |
✘
|
Biophysical techniques |
✔
GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
PubMed ID |
Unpublished / Not applicable
|
Organism |
Homo sapiens |
Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
Journal name |
Mesenchymal Stem Cell Therapy
|
Publication year |
2011 |
Sample |
Mesenchymal stem cells |
Sample name |
huES9.E1 |
Isolation/purification methods |
HPLC |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
12 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
13 |
Experiment ID |
211 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
cytochrome c|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
14 |
Experiment ID |
212 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
Cytochrome C|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
138 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
16 |
Experiment ID |
140 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
17 |
Experiment ID |
141 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
18 |
Experiment ID |
142 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
LNCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
19 |
Experiment ID |
144 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
20 |
Experiment ID |
145 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
21 |
Experiment ID |
146 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
RWPE - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
22 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
23 |
Experiment ID |
191 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD81|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20124223
|
Organism |
Homo sapiens |
Experiment description |
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. |
Authors |
"Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2010 |
Sample |
Squamous carcinoma cells |
Sample name |
Squamous carcinoma cell (A431) |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
24 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for HIST1H2AE |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
HLTF |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
2 |
XPC |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
3 |
RPL26L1 |
51121 |
Affinity Capture-MS |
 |
Homo sapiens |
|
4 |
MRPL48 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
5 |
HMCES |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
6 |
MRPL17 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
7 |
RPS17 |
6218 |
Affinity Capture-MS |
 |
Homo sapiens |
|
8 |
ANAPC5 |
51433 |
Affinity Capture-MS |
 |
Homo sapiens |
|
9 |
EPB41L5 |
57669 |
Affinity Capture-MS |
 |
Homo sapiens |
|
10 |
HIST1H2BJ |
8970 |
Affinity Capture-MS |
 |
Homo sapiens |
|
11 |
RPS19 |
6223 |
Affinity Capture-MS |
 |
Homo sapiens |
|
12 |
MRPL10 |
124995 |
Affinity Capture-MS |
 |
Homo sapiens |
|
13 |
HNRNPD |
3184 |
Affinity Capture-MS |
 |
Homo sapiens |
|
14 |
CAND1 |
55832 |
Affinity Capture-MS |
 |
Homo sapiens |
|
15 |
PARK7 |
11315 |
Affinity Capture-MS |
 |
Homo sapiens |
|
16 |
MSH3 |
4437 |
Affinity Capture-MS |
 |
Homo sapiens |
|
17 |
UTP3 |
57050 |
Affinity Capture-MS |
 |
Homo sapiens |
|
18 |
RPS3 |
6188 |
Affinity Capture-MS |
 |
Homo sapiens |
|
19 |
USP36 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
20 |
COPS5 |
10987 |
Affinity Capture-MS |
 |
Homo sapiens |
|
21 |
XRCC1 |
7515 |
Affinity Capture-MS |
 |
Homo sapiens |
|
22 |
WDR76 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
23 |
MCM2 |
4171 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
24 |
MPHOSPH10 |
10199 |
Affinity Capture-MS |
 |
Homo sapiens |
|
25 |
PLK4 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
26 |
IMPDH2 |
3615 |
Proximity Label-MS |
 |
Homo sapiens |
|
27 |
NPM1 |
4869 |
Proximity Label-MS |
 |
Homo sapiens |
|
28 |
PHF14 |
9678 |
Affinity Capture-MS |
 |
Homo sapiens |
|
29 |
H2AFY2 |
55506 |
Affinity Capture-MS |
 |
Homo sapiens |
|
30 |
KRI1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
31 |
MCM6 |
4175 |
Affinity Capture-MS |
 |
Homo sapiens |
|
32 |
MRPL57 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
33 |
SPTY2D1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
34 |
GINS4 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
35 |
ITGA4 |
3676 |
Affinity Capture-MS |
 |
Homo sapiens |
|
36 |
DDX18 |
8886 |
Affinity Capture-MS |
 |
Homo sapiens |
|
37 |
NAP1L4 |
4676 |
Reconstituted Complex |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
38 |
FAM111A |
63901 |
Affinity Capture-MS |
 |
Homo sapiens |
|
39 |
CUL1 |
8454 |
Affinity Capture-MS |
 |
Homo sapiens |
|
40 |
SOD1 |
6647 |
Affinity Capture-MS |
 |
Homo sapiens |
|
41 |
HIST2H4A |
8370 |
Affinity Capture-MS |
 |
Homo sapiens |
|
42 |
CTCF |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
43 |
CCDC86 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
44 |
ZCRB1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
45 |
HIST2H3PS2 |
440686 |
Affinity Capture-MS |
 |
Homo sapiens |
|
46 |
PPM1B |
5495 |
Affinity Capture-MS |
 |
Homo sapiens |
|
47 |
H2AFZ |
3015 |
Affinity Capture-MS |
 |
Homo sapiens |
|
48 |
TRIM41 |
90933 |
Affinity Capture-MS |
 |
Homo sapiens |
|
49 |
DLD |
1738 |
Affinity Capture-MS |
 |
Homo sapiens |
|
50 |
HIST2H2AB |
317772 |
Affinity Capture-MS |
 |
Homo sapiens |
|
51 |
COX15 |
1355 |
Affinity Capture-MS |
 |
Homo sapiens |
|
52 |
CDC23 |
8697 |
Affinity Capture-MS |
 |
Homo sapiens |
|
53 |
CUL4B |
8450 |
Affinity Capture-MS |
 |
Homo sapiens |
|
54 |
RPS10 |
6204 |
Affinity Capture-MS |
 |
Homo sapiens |
|
55 |
HIST1H2AG |
8969 |
Affinity Capture-MS |
 |
Homo sapiens |
|
56 |
LARP7 |
51574 |
Affinity Capture-MS |
 |
Homo sapiens |
|
57 |
APOBEC3C |
27350 |
Affinity Capture-MS |
 |
Homo sapiens |
|
58 |
POLR3F |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
59 |
CFDP1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
60 |
RPL31 |
6160 |
Affinity Capture-MS |
 |
Homo sapiens |
|
61 |
RAD18 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
62 |
GINS1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
63 |
DHFRL1 |
|
Proximity Label-MS |
 |
Homo sapiens |
|
64 |
ANAPC4 |
29945 |
Affinity Capture-MS |
 |
Homo sapiens |
|
65 |
HIST1H2BK |
85236 |
Affinity Capture-MS |
 |
Homo sapiens |
|
66 |
PELP1 |
27043 |
Affinity Capture-MS |
 |
Homo sapiens |
|
67 |
H2AFY |
9555 |
Affinity Capture-MS |
 |
Homo sapiens |
|
68 |
PPM1G |
5496 |
Affinity Capture-MS |
 |
Homo sapiens |
|
69 |
DNM1L |
10059 |
Affinity Capture-MS |
 |
Homo sapiens |
|
70 |
PRKACB |
5567 |
Affinity Capture-MS |
 |
Homo sapiens |
|
71 |
NFX1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
72 |
PURB |
5814 |
Affinity Capture-MS |
 |
Homo sapiens |
|
73 |
IPO9 |
55705 |
Affinity Capture-MS |
 |
Homo sapiens |
|
74 |
TONSL |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
75 |
MIER3 |
166968 |
Affinity Capture-MS |
 |
Homo sapiens |
|
76 |
MIER1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
77 |
HIST1H3F |
8968 |
Affinity Capture-MS |
 |
Homo sapiens |
|
78 |
SPATS2L |
26010 |
Affinity Capture-MS |
 |
Homo sapiens |
|
79 |
DAP3 |
7818 |
Affinity Capture-MS |
 |
Homo sapiens |
|
80 |
DHX36 |
170506 |
Affinity Capture-MS |
 |
Homo sapiens |
|
81 |
SDHA |
6389 |
Affinity Capture-MS |
 |
Homo sapiens |
|
82 |
YTHDC2 |
64848 |
Affinity Capture-MS |
 |
Homo sapiens |
|
83 |
EPAS1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
84 |
RLIM |
51132 |
Affinity Capture-MS |
 |
Homo sapiens |
|
85 |
MRPL27 |
51264 |
Affinity Capture-MS |
 |
Homo sapiens |
|
86 |
MRPL16 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
87 |
HYPK |
25764 |
Affinity Capture-MS |
 |
Homo sapiens |
|
88 |
RPL3 |
6122 |
Affinity Capture-MS |
 |
Homo sapiens |
|
89 |
ZC3H8 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
90 |
HSD17B10 |
3028 |
Affinity Capture-MS |
 |
Homo sapiens |
|
91 |
GADD45GIP1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
92 |
MCM4 |
4173 |
Affinity Capture-MS |
 |
Homo sapiens |
|
93 |
NAP1L1 |
4673 |
Affinity Capture-MS |
 |
Homo sapiens |
|
94 |
SUZ12 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
95 |
CLSPN |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
96 |
NXF1 |
10482 |
Affinity Capture-RNA |
 |
Homo sapiens |
|
97 |
GINS3 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
98 |
ZNF512 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
99 |
CDYL |
9425 |
Affinity Capture-MS |
 |
Homo sapiens |
|
100 |
SS18L2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
101 |
LTV1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
102 |
DLST |
1743 |
Affinity Capture-MS |
 |
Homo sapiens |
|
103 |
PRDM13 |
59336 |
Affinity Capture-MS |
 |
Homo sapiens |
|
104 |
ZFP91 |
80829 |
| | | |